2 Healthcare stocks jump up to 4% after announcing its Q3 results

Synopsis: Dr Agarwals Eye Hospital Limited reports 21.14% YoY revenue growth and a 66.15% YoY net profit surge in Q3 FY26 results. Similarly, Dr Agarwal’s Health Care Limited achieved a 23.02% YoY revenue growth and a 52.34% YoY net profit surge in Q3 FY26 results.

Two small-cap healthcare stocks have drawn investor attention after reporting more than 50 percent year-on-year growth in net profit. The strong performance reflects rising patient volumes, improved operational efficiency, and better margin management. Both companies demonstrated solid execution and recovery momentum, highlighting how select healthcare small-caps can benefit from growing medical demand while delivering strong earnings growth and long-term investor value. Here are two Small-cap Healthcare stocks that announced more than 50% YOY increase in net profit

Dr Agarwal’s Eye Hospital Limited

With a market capitalization of Rs. 2,319.76 crores, the share of Dr Agarwals Eye Hospital Limited has reached an intraday high of Rs. 4,825 per equity share, rising nearly 3.17 percent from its previous day’s close price of Rs. 4,676.95. Since then, the stock has retreated and is currently trading at Rs. 4,800 per equity share. 

Q3 FY26 Result Walkthrough

Coming into the quarterly results of Dr Agarwals Eye Hospital Limited, the company’s consolidated revenue from operations increased by 21.14 percent YOY, from Rs. 95.11 crore in Q3 FY25 to Rs. 115.22 crore in Q3 FY26, and decreased by 2.12 percent QoQ from Rs. 117.72 crore in Q2 FY26.

In Q3 FY26, Dr Agarwals Eye Hospital Limited’s consolidated net profit increased by 66.15 percent YOY, reaching Rs. 17.28 crore compared to Rs. 10.40 crore during the same period last year. As compared to Q2 FY26, the net profit has decreased by 10.56 percent, from Rs. 19.32 crore. The basic earnings per share increased by 32.98 percent and stood at Rs. 37.14 as against Rs. 27.93 recorded in the same quarter in the previous year, FY2025.

Dr Agarwal’s Eye Hospital Limited was established in 1994 and is headquartered in Chennai, and is one of India’s leading eye care providers. The company offers comprehensive ophthalmology services, including cataract, retinal, refractive, and corneal treatments. It operates a large multi-centre network across India and international markets using a hub-and-spoke model.

Dr Agarwal’s Health Care Limited

With a market capitalization of Rs. 14,275.35 crores, the share of Dr Agarwals Health Care Limited has reached an intraday high of Rs. 461.10 per equity share, rising nearly 3.51 percent from its previous day’s close price of Rs. 445.45. Since then, the stock has retreated and is currently trading at Rs. 450.60 per equity share. 

Q3 FY26 Result Walkthrough

Coming into the quarterly results of Dr Agarwals Health Care Limited, the company’s consolidated revenue from operations increased by 23.02 percent YOY, from Rs. 430.72 crore in Q3 FY25 to Rs. 529.86 crore in Q3 FY26, and grew by 6.25 percent QoQ from Rs. 498.69 crore in Q2 FY26. Further, the company’s EBITDA has increased by 21.09 percent, from Rs. 128 crore in Q3 FY25 to Rs. 155 crore in Q3 FY26. 

In Q3 FY26, Dr Agarwals Health Care Limited’s consolidated net profit increased by 52.34 percent YOY, reaching Rs. 43.63 crore compared to Rs. 28.64 crore during the same period last year. As compared to Q2 FY26, the net profit has increased by 19.57 percent, from Rs. 36.49 crore. The basic earnings per share increased by 46.58 percent and stood at Rs. 1.07 as against Rs. 0.73 recorded in the same quarter in the previous year, FY2025.

Dr Agarwal’s Health Care Limited was incorporated in 2010 and is headquartered in Chennai.  The company serves as the parent entity overseeing India’s largest eye care chain across India and abroad. It delivers end-to-end ophthalmology services through a hub-and-spoke model, encompassing cataract surgeries, refractive procedures, retinal care, consultations, diagnostics, non-surgical treatments, opticals, and pharmaceuticals. 

Dr Agarwal’s Health Care Limited expanded its network to 272 eye care facilities by December 2025, adding 38 centres in nine months. The company served over 22 lakh patients and performed more than 238,000 surgeries, supported by more than 900 doctors, strengthening its leadership in specialized eye care services across India.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post 2 Healthcare stocks jump up to 4% after announcing its Q3 results appeared first on Trade Brains.